Login
$ACAD
$18.47 -$0.20 (1.07%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Owen Adams Also a director
Chief Executive Officer
55 Not stated Not stated Not reported
Mark C. Schneyer
Executive Vice President and Chief Financial Officer
Not stated Since 2021
5 years
2020 Not reported
Jennifer J. Rhodes
Executive Vice President, Chief Legal Officer and Secretary
Not stated Not stated 2024 Not reported
Thomas Garner
Executive Vice President and Chief Commercial Officer
Not stated Since 2024
2 years
Not stated $857,023
James Kihara
PRINCIPAL ACCOUNTING OFFICER
Title from the Form 4 dated Jun 26, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
8.0 years
from year joined
CEO also chairs the board
No
Stephen R. Biggar
Director Age On board Independent Committees Other public boards 2025 pay Source
Stephen R. Biggar
55 2013
13 years
Independent None stated Kiniksa Pharmaceuticals, Ltd., TScan Therapeutics, Inc. $415,542
Catherine Owen Adams
55 2024
2 years
Not independent None stated Agios Pharmaceuticals, Inc. Paid as CEO
Julian C. Baker
59 2015
11 years
Independent None stated Incyte Corporation, Madrigal Pharmaceuticals, Inc., Denali Therapeutics, Inc. $385,049
Laura A. Brege
68 2008
18 years
Independent
Nominating and Corporate Governance Committee · Chair
Edgewise Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Pacira BioSciences, Inc., T-knife Therapeutics, Inc. $395,212
James M. Daly
64 2016
10 years
Independent None stated Argenx SE, Cytokinetics, Incorporated, Madrigal Pharmaceuticals, Inc. $393,942
Elizabeth A. Garofalo
68 2020
6 years
Independent None stated Alector, Inc., Xenon Pharmaceuticals Inc. $392,671
Adora Ndu
45 2022
4 years
Independent None stated DBV Technologies S.A. $400,294
Jonathan Poole
51 2026
this year
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 24, 2026
entities affiliated with Baker Bros. Advisors LP
holders of more than 5% of our capital stock; affiliated with directors Mr. Baker and Dr. Biggar
Amount not stated

Registration rights agreements (dated January 6, 2016 and February 24, 2026) providing certain holders of capital stock with registration rights, including demand and piggyback rights.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support